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Abstract
Background: Amplicon deep sequencing permits sensitive detection of minority clones and improves discriminatory
power for genotyping multi-clone Plasmodium falciparum infections. New amplicon sequencing and data analysis
protocols are needed for genotyping in epidemiological studies and drug efficacy trials of P. falciparum.
Methods: Targeted sequencing of molecular marker csp and novel marker cpmp was conducted in duplicate on
mixtures of parasite culture strains and 37 field samples. A protocol allowing to multiplex up to 384 samples in a single
sequencing run was applied. Software “HaplotypR” was developed for data analysis.
Results: Cpmp was highly diverse (He = 0.96) in contrast to csp (He = 0.57). Minority clones were robustly detected
if their frequency was >1%. False haplotype calls owing to sequencing errors were observed below that
threshold.
Conclusions: To reliably detect haplotypes at very low frequencies, experiments are best performed in duplicate and
should aim for coverage of >10′000 reads/amplicon. When compared to length polymorphic marker msp2, highly
multiplexed amplicon sequencing displayed greater sensitivity in detecting minority clones.
Keywords: Plasmodium falciparum, Malaria, Amplicon sequencing, SNP, Haplotype clustering, Multi-clone infections,
msp2, csp, cpmp, HaplotypR software
Background
In infection biology of malaria as well as of many other
pathogens, detection of minority clones is a crucial task.
In areas of high malaria transmission, most infected
hosts harbour multiple clones of the same Plasmodium
species. To better understand the epidemiology and in-
fection dynamics of malaria, individual parasite clones
are tracked over time to measure the acquisition, elimin-
ation and persistence of individual clones in a human
host. The incidence of new clones per host serves as sur-
rogate measure for the exposure of an individual and for
the transmission intensity in a population [1].
Identification of new infections is also crucial in clinical
trials of antimalarial drugs, where persisting clones need
to be distinguished from new clones in post-treatment
samples from patients with recurrent parasitaemia [2, 3].
For such diverse applications, genotyping methods based
on length polymorphic markers had been applied for
decades, particularly by targeting microsatellite markers
or genes encoding parasite surface antigens such as
merozoite surface proteins 1 and 2 (msp1, msp2) [4, 5].
Despite their wide use in many malaria research
laboratories, length polymorphic markers have important
limitations. For example, microsatellite typing suffers from
frequent occurrence of stutter peaks, possibly resulting
from polymerase slippage on stretches of simple tandem
repeats. A cut-off requirement for a minimal peak height
(e.g. 33% of the predominant peak [6]) is required to
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prevent scoring of artefact fragments. However, this cut-
off makes it impossible to detect minority clones falling
below the selected threshold. Another limitation of length
polymorphic marker, particularly the highly polymorphic
parasite surface antigens, consists in the usually large size
differences between alleles. Major size differences lead to
bias in amplification, preferring the shorter PCR frag-
ments in samples that concurrently contain multiple P.
falciparum infections [7].
Deep sequencing of short amplicons has the potential
to overcome some of the shortfalls of length poly-
morphic genotyping markers, in particular the influence
of fragment length of a marker on the detectability of
minority clones. Earlier studies used two different ap-
proaches for genotyping of P. falciparum and P. vivax by
amplicon deep sequencing: (i) Sequencing of the clas-
sical length polymorphic genotyping markers, such as P.
falciparum msp1 and msp2 [8]. Alternatively, sequencing
targeted non-repetitive regions that harbour extensive
single nucleotide polymorphism (SNP), such as the P.
falciparum circumsporozoite protein (csp) or P. vivax
msp1 [9–11]. The strength of these approaches is that all
SNPs within an amplicon are linked by a single sequence
read, leading directly to haplotype identification. (ii) Se-
quencing of multiple loci of genome-wide distribution,
whereby each locus comprises one SNP [12]. This latter
approach is particularly suited for population genetic in-
vestigations, as these loci are not linked. The downside
is that the haplotype of each infecting clone has to be re-
constructed, which is difficult or even impossible for
samples with a high number of co-infecting clones per
host [13]. Thus, genotyping of samples containing multi-
clone infections remains an unresolved challenge when
multiple genome-wide loci are targeted.
In previous studies, amplicon deep sequencing was per-
formed on two platforms, 454/Roche or Ion Torrent. In
the past these technologies have produced longer se-
quences than the 37 bp reads obtained by the Illumina
sequencing platform. Now Illumina MiSeq generates reads
of up to 600 bp length (Illumina, MiSeq Reagent Kit v3).
Sequencing error rates of 454/Roche and Ion Torrent
technologies were high, owing to insertion and deletion
(indel) errors occurring predominantly in homopolymeric
regions [14–16]. Illumina sequencing is less susceptible to
indel errors and has an overall smaller error rate [16].
The present report outlines a strategy and protocols for
identifying highly diverse markers for SNP-based genotyp-
ing of P. falciparum by amplicon sequencing. The primary
aim was to thoroughly assess the analytical sensitivity and
specificity of amplicon sequencing in detecting minority
clones. In epidemiological studies involving hundreds of
samples sequencing costs per sample are crucial. There-
fore we designed a highly multiplexed protocol, allowing
sequencing of up to 384 barcoded P. falciparum
amplicons in a single Illumina MiSeq run. Because mul-
tiple concurrent P. falciparum clones may differ greatly in
density, sequencing analysis strategies need to identify
alleles of very low abundance. To distinguish true minor-
ity clones from sequencing errors, quality checks were
designed based on replicates of samples and integrated
into the sequence analysis pipeline. The newly created
data analysis software package was validated using experi-
mental mixtures of P. falciparum in vitro culture strains,
and tested on field samples.
Results
Marker selection
A protocol for deep sequencing and data analysis was devel-
oped for two molecular markers, namely the P. falciparum
csp gene (PF3D7_0304600) and gene PF3D7_0104100,
annotated in the malaria sequence database PlasmoDB as
“conserved Plasmodium membrane protein” (cpmp). Results
from these two markers were compared with classical length
polymorphic genotyping using the highly diverse marker
msp2. Sizes of msp2 fragments amplified for genotyping
range from 180 to 515 bp in PNG using published primers
(Additional file 1: Table S1). Marker csp has been used for
deep sequencing in the past [9] and the previously published
primers (Additional file 1: Table S1) were used. The csp
amplicon spans the T-cell epitope of the circumsporozoite
protein from nucleotide position 858 to 1186 of the 3D7
reference sequence.
The newly validated marker cpmp was identified by
calculating heterozygosity in 200 bp windows of 3′411
genomic P. falciparum sequences from 23 countries
available from the MalariaGEN dataset [17]. Genes from
multi-gene families or regions of poor sequence align-
ments, often caused by length polymorphism of intragenic
tandem repeats, were excluded from the list of potential
markers. A 430 bp fragment of cpmp spanning nucleotide
positions 1895 to 2324 scored highest in expected hetero-
zygosity (He) and was prioritized as candidate for a highly
diverse amplicon sequencing marker. He in the worldwide
dataset was 0.93 for cpmp compared to 0.86 for csp
(Table 1, Additional file 1: Figure S1 and S2). Genomes
originating from Papua New Guinea (PNG) revealed 9
haplotypes in 22 genomes for cpmp and 3 haplotypes in
30 genomes for csp.
Assessment of sequence quality
Csp and cpmp amplicons from 37 field samples and 13
mixtures of P. falciparum culture strains HB3 and 3D7
were sequenced on Illumina MiSeq in paired-end mode.
A total of 5′810′566 paired raw sequences were re-
trieved. Of all reads, 326′302 mapped to the phiX refer-
ence sequence. 4′989′271 paired sequence reads were
successfully de-multiplexed to yield a set of amplicon se-
quences per individual sample. 4′411′214 reads could be
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assigned to individual amplicons. Median sequence
coverage over all sequenced samples was 1′490 for
cpmp (1st and 3rd quartiles: [537, 2183]) and 731 for
csp (1st and 3rd quartiles: [524, 1092]). The discrep-
ancy in median sequence coverage was deliberate and
resulted from our pooling strategy to underrepresent
csp amplicons to prevent their predominance in the
sequencing library due to this amplicon’s shorter
length (Additional file 1).
The quality of the sequence run was assessed by inves-
tigating the sequencing error rate in sequence reads of
the spiked-in phiX control. The mean mismatch rate per
nucleotide of phiX control reads with respect to the
phiX174 genome was 5.2% (median 0.34%). The mis-
match rate increased towards the end of sequence reads,
up to 11% for forward reads and 54% for reverse reads
(Additional file 1: Figure S3). To censor regions of high
mismatch rates, forward and reverse sequence reads
were trimmed before any further analyses to a length of
240 and 170 nucleotides, respectively. After trimming,
the mean mismatch rate per nucleotide of phiX control
reads was 0.50%.
As further quality check, the sequencing error rate was
assessed in sequences of Linkers F and R (Additional file 1:
Figure S4). These linker sequences never get amplified but
are joined to the product in PCR, therefore any mismatch
detected in these stretches will derive from either sequen-
cing or initial primer synthesis. The average number of se-
quence mismatches in this part was 0.12% per sample per
nucleotide (Additional file 1: Table S2 and Figure S5). The
sequencing error rate also was assessed in regions corre-
sponding to the primers of each marker (Additional file 1:
Figure S4). Mismatches with respect to the known se-
quences of the PCR primers may derive from amplifica-
tion errors or from errors in sequencing or primer
synthesis during preparation of the sequencing library.
The average number of mismatches in the primer regions
was 0.28% for cpmp and 0.71% for csp per nucleotide per
sample (Additional file 1: Figure S6 and Table S2).
Finally, the sequencing error rate was assessed in ampli-
cons obtained from various mixtures of P. falciparum cul-
ture strains HB3 and 3D7. Potential sources of mismatches
with respect to the reference sequence of strains 3D7 and
HB3 include amplification error, sequencing error and er-
rors due to de-multiplexing of samples [18]. The average
number of sequence mismatches after trimming to
lengths of 240 and 170 nucleotides respectively for
forward and reverse reads was 0.38% for cpmp and
0.46% for csp (Fig. 1, Additional file 1: Table S2). This
equates to 1–2 mismatches per read of 310 nucleotides.
On average 87.5% of reads for cpmp and 85.5% for csp
from mixtures of strains HB3 and 3D7 contained ≤2
mismatches per read with respect to the strains’ reference
sequences. Together the analyses of phiX and HB3/3D7
sequences indicated an intrinsic sequence error rate of
0.4–0.5%. The error rate of the linker sequence suggested
that one third of these errors were sequencing errors,
while two thirds were amplification errors.
Limit of detection assessed in serial dilutions of parasite
culture
To test the feasibility to also genotype blood samples of
low parasite density, serial dilutions of P. falciparum strain
3D7 over 5 orders of magnitude (5–50′000 parasites/μl)
were sequenced (Additional file 1: Table S3). The 3D7
haplotype was detected in all dilutions. However, se-
quence coverage for dilutions harbouring 5 and 50
parasites/μl was below 550 reads. This indicated that
the desired equimolar representation of amplicons was
not achieved by our pooling strategy (Additional file 1
Pooling of samples - Pool for PCR without visible product
on agarose gel). Our approach did not fully counterbal-
ance lower amounts of amplicon.
Assessment of minority clone detectability
Defined mixtures of P. falciparum strains HB3 and 3D7
were sequenced to assess the detectability of minority
clones under controlled conditions. The minority clone
was detected in all tested dilution ratios up to 1:3000
(Table 2, Additional file 1: Table S4 and S5). Reads com-
prising obvious PCR artefacts (indels and chimeras) were
detected in these mixtures up to a frequency of 0.48%
for marker cpmp and 6.2% for csp. Up to 8.4% of reads
for cpmp and 10.8% for csp were singletons or failed to
cluster with 3D7 or HB3 haplotypes. This proportion of
reads is therefore most likely an estimate of the cumula-
tive background noise of the methodology. These reads
fell below the default cut-off criteria (details below) and
were thus excluded.
Simulations by bootstrap resampling were applied to esti-
mate the probability to detect a minority clone at increasing
sequencing coverage and decreasing ratios of the minority
clone in a mixture of two strains. Resampling was repeated
1000 times and included only sequence data from mixtures
of strains that were sequenced at a coverage of >3000 reads.
At a coverage of 10′000 sampled reads the minority clone
Table 1 Diversity of markers cpmp and csp based on 3′411
genomes of the MalariaGen dataset
Marker He
a No. of SNPs Fragment sizeb No. of Haplotypes
cpmp 0.930c 20c 383c 82 of 980c,d
csp 0.857 40 287 77 of 1323d
aExpected heterozygosity
bFragment size without primer sequence
cTrimming of reads in the here presented experiments led to a reduction of
variation (Characteristics for a shorter cpmp fragment size of 310 bp:
He = 0.913, SNPs = 14 and number of haplotypes = 47)
dFrom 3411 genomes only genomes with non-ambiguous SNP calls in selected
region were used
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was robustly detected at ratios 1:1 to 1:1000 for cpmp and
up to 1:500 for csp (Fig. 2, Additional file 1: Figure S7 and
S8). The cut-off set for haplotype positivity required that a
haplotype was detected ≥3 times and represented ≥0.1% of
all reads from the respective blood sample. More stringent
criteria to call a haplotype (i.e. a higher minimum number
of reads) would require a higher coverage for the detection
of minority clones. Thus, more stringency in haplotype def-
inition on the one hand reduces sensitivity, but increases
specificity by eliminating false haplotypes attributable to
background noise (Additional file 1: Figure S7 and S8).
Specification of default cut-off settings in software HaplotypR
Cut-off values for the analysis of sequencing data were
defined to support removal of background noise caused
by sequencing and amplification errors. The following
values represent minimal stringency and can be adjusted
to higher stringency to increase specificity in the
HaplotypR pipeline:
(i) Cut-off settings for SNP calling were defined by a
population-based approach. A SNP was required to
be dominant (>50% of all reads) in ≥2 samples. A
single dominant occurrence of a SNP is likely caused
by amplification or sequencing error.
(ii)Cut-off settings for haplotype calling required a
haplotype to be supported by ≥3 reads in ≥2 samples
(including independent replicates of the same
sample). Per haplotype a minimum of 3 reads are
needed to distinguish SNPs from sequencing errors,
Fig. 1 Mismatch rate per nucleotide position derived from all samples sequenced for markers cpmp and csp. Each data point represents the mean
observed mismatch rate observed in all reads of one sample at the respective nucleotide position. Red data points: control samples (P. falciparum
culture strains); black data points: field samples; X-axis: nucleotide position in sequenced fragment; Y-axis: mismatch rate with respect to the reference
sequence (for control samples: sequences of strains 3D7 and HB3, for field samples, 3D7 sequence); dashed grey lines represent SNPs with a mismatch
rate of >0.5 in >1 sample; red dotted horizontal line indicates a mismatch rate of 0.5; solid black vertical line: position of concatenation of forward and
reverse reads
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because a consensus sequence cannot be determined
from 2 disparate reads alone. Random sequencing
and amplification errors would unlikely lead
repeatedly to a particular haplotype.
(iii)Cut-off settings for calling minority clones required
that a minority clone would represent at least 0.1%
of all reads of a sample, which corresponds to a
detection limit for minority clones of 1:1000. For the
current project, the cut-off was justified by the
results obtained from artificial mixtures of culture
strains, which defined the technical limit of
detection for a minority clone. This parameter may
be set to more stringent values.
Application of these three default cut-off values to
mixtures of culture strains had the effect that HaplotypR
missed the minority clone for both markers in the great-
est dilution ratio of the two strains tested (1:3000). For
marker csp the minority clone fell below the cut-off even
in the 1:1500 ratio (Table 2). No false-positive haplotypes
were called after applying default cut-off criteria, even in
samples with a very high coverage in the controlled mix-
tures (up to 55′000 reads) and in simulations by boot-
strapping (up to 100′000 sampled reads) (Additional
file 1: Table S4 and S5).
Validation of SNP calling
The above criteria were validated on reads from culture
strains and primer sequences. The background sequen-
cing error rate at each individual nucleotide position was
measured to distinguish sequencing and amplification
errors from true SNPs. Mismatch rates of up to 22% was
measured in primer sequences (Additional file 1: Figure
S6), and 18% in amplicons from culture strains (Fig. 1,
Additional file 1: Table S2). None of these mismatches
Fig. 2 Simulation of minority clone detectability by bootstrapping for marker cpmp and csp. Cut-off for acceptance of a haplotype was a minimum
coverage per haplotype of 3 reads and a minority clone detection limit of 1:1000. Samples were drawn from reads of defined mixtures of P. falciparum
strain 3D7 and HB3. X-axis shows dilution ratios of strains 3D7 and HB3; Y-axis indicates the sampling size (number of draws from sequence reads) for
each mixture of strains. Sampling was repeated 1000 times to estimate mean minority clone detectability
Table 2 Detectability of the minority clone in defined ratios of P. falciparum strains HB3 and 3D7




















1:1 34.6 57.4 0.48 7.53 40,768 34.7 50.5 5.79 9.01 9009 6
1:10 75.6 16.4 0.40 7.59 13,037 76.1 10.1 5.63 8.08 3341 30
1:50 88.8 3.15 0.06 7.95 4953 82.7 2.88 6.23 8.16 14,711 150
1:100 90.9 1.53 0.36 7.26 13,311 83.5 2.25 5.41 8.88 11,975 300
1:500 90.8 0.48 0.27 8.44 5649 84.0 0.46 4.76 10.8 3508 1500
1:1000 91.5 0.23 0.03 8.26 3039 85.7 0.22 5.09 9.02 1807 3000
1:1500 92.5 0.11 0.48 6.94 55,887 86.3 0.08d 5.71 7.91 23,619 4500
1:3000 92.5 0.094 0.38 7.00 7417 85.0 0.04d 5.87 9.10 2318 9000
a Percent of reads that cluster with 3D7 and HB3 reference sequences
b Singleton reads and reads that failed to cluster with 3D7 or HB3 haplotypes
c Theoretical minimum required coverage needed to detect minority clone by software HaplotypR with default cut-off values
d Haplotypes considered as noise by software HaplotypR (default cut-off: ≥3 reads per haplotype and a minority clone detection limit of 1:1000)
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led to calling of a SNP after the above cut-off was
applied (i.e. >50% of reads in ≥2 samples).
Validation of amplicon sequencing in field samples
37 P. falciparum samples from PNG were genotyped by
amplicon sequencing. Dendrograms were produced for
each marker from raw sequencing reads (Fig. 3, Additional
file 1: Figure S9). Branch lengths in these dendrograms rep-
resent the number of SNPs that differ between any se-
quences compared. Branches with sequences belonging to
the same haplotype (defined as “clusters”) are labelled in
the same colour. Haplotype frequencies within each indi-
vidual sample were determined from the reads of the sam-
ple before applying cut-offs (Fig. 3, panel “Quantification”).
When analysing the genetic diversity in field sample, hap-
lotypes were only counted as true haplotypes if both
replicates pass the haplotype calling cut-off. This more
stringent criterion was introduced to prevent erroneous
over-estimation of multiplicity due to false haplotypes.
All samples were genotyped for length polymorphic
marker msp2 using capillary electrophoresis (CE) for frag-
ment sizing. Msp2 genotyping was reproducible and con-
sistent between different laboratories (Fig. 3, Additional
file 1: Figure S9: left column). A mean multiplicity of in-
fection (MOI) of 2.2 was observed in 37 field samples ana-
lysed by msp2 genotyping and 25/37 (67.5%) of samples
harboured multiple clones (Fig. 4, Additional file 1: Table
S6). Mean MOI and He were compared between the
Fig. 3 Comparison of genotyping by length-polymorphic marker msp2 and amplicon sequencing of cpmp and csp. Raw data from length-
polymorphism- and SNP-based genotyping for one P. falciparum-positive field sample. Left panel: Capillary electropherograms (CE) for
msp2 nested PCR products (duplicate experiments); X-axis: fragment length, Y-axis: peak heights (arbitrary intensity units); size standards: red/orange
peaks; 3D7-type msp2 genotypes: green peaks; FC27-type msp2 genotypes: blue peaks. Middle and right panel: Dendrograms derived from sequence
reads of marker cpmp (middle) and csp (right); coloured lines represent membership to a specific, colour-coded haplotype; Grey lines: sequence reads
of PCR artefacts (later excluded by cut-off settings); line length: number of mismatches according to bar insert. Bottom panels: Read counts (n) and
percentage of reads (%) per haplotype and final multiplicity call
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genotyping methods (Table 3, Fig. 4, Additional file 1:
Table S6). The resolution of marker cpmp was slightly
higher than that of msp2 with 27 cpmp haplotypes
versus 25 msp2 alleles, He of 0.96 versus 0.95 and a
higher mean MOI of 2.41 versus 2.19, respectively.
Overall the two methods agreed well, with good con-
cordance of MOI (Cohen’s Kappa 0.71, equal weights,
z = 6.64, p-value = 3.04e-11). Compared to msp2 the
discriminatory power of csp was substantially lower
with only 4 csp haplotypes found in 37 samples, He
of 0.57 and mean MOI of 1.54. Concordance between
csp and msp2 MOI was poor (Cohen’s Kappa 0.38,
equal weights, z = 4.48, p-value = 7.61e-6).
Reproducibility of amplicon sequencing in field samples
Csp and cpmp haplotypes obtained from 37 field samples
were compared between replicates to investigate reprodu-
cibility of the molecular and bioinformatic analyses. For
both replicates of the field samples the default cut-off cri-
teria for haplotype calling (≥3 reads and minority clone
detection limit of 1:1000) were applied. Concordance be-
tween replicates was very good with Cohen’s Kappa 0.84
(equal weights, z = 7.769, p-value = 7.99e-15) for cpmp
and 0.91 (equal weights, z = 6.466, p-value = 1.01e-10) for
csp. Comparison of replicates permitted to investigate the
amount of false haplotype calls. True haplotypes should
be detected in both replicates, unless the sequence depth
Fig. 4 Frequency distribution of multiplicity of infection and allelic frequencies of cpmp, csp and msp2-CE. 37 P. falciparum positive samples from
PNG were analysed for the 3 markers cpmp (27 haplotypes), csp (4 haplotypes) and msp2-CE (25 genotypes). Pie charts represent allelic frequency
distribution for each marker in 37 samples
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is not sufficient for detecting a minority clone in one of
the replicates. Cpmp minority clones that had a fre-
quency > 1.0% of all reads were consistently detected with
≥3 reads in both replicates (Table 4, Additional file 1: Fig-
ure S10). For csp this was achieved for minority clones
with a frequency of >0.70%. 18 cpmp haplotypes were de-
tected with ≥3 reads in only one of the replicates. In three
instances one of the replicate did not pass the cut-off cri-
teria due to low coverage. For marker csp, 2 haplotypes
with ≥3 reads were detected in one replicate only. In sum-
mary, a comparison of replicates indicated 15 potentially
false haplotype calls for cpmp and 2 for csp. These calls
stem from reads with a frequency < 1%, Therefore, per-
forming replicates are essential to prevent erroneous over-
estimation of multiplicity due to false haplotypes.
An attempt was made to investigate the influence of
the number of PCR cycles performed during amplicon
library preparation on the generation of artefacts. This
was possible by using 25 and 15 cycles in the nested
PCR for replicate 1 and 2, respectively. Cycle number
had no influence on the proportion of singleton and
indel reads. However, the proportion of chimeric cpmp
reads was higher in replicate 1 using 25 cycles than in
replicate 2 using 15 cycles (0.63% versus 0.13%, Student’s
t-Test P-value = 0.0221). No chimeric csp reads were
detected in the field samples (Table 5).
Discussion
This report presents the development of a new genotyp-
ing methodology for P. falciparum based on amplicon
deep sequencing. The search for new markers was
prompted by severe limitations of length polymorphic
markers, which represent the currently used standard
for genotyping malaria parasites. A strong bias towards
preferential amplification of shorter fragments in multi-
clone infections was observed, so that larger fragments
were lost even if only 5-fold underrepresented com-
pared to shorter fragments from the same sample [7].
This called for an alternative approach that relies on
haplotypes created from several SNPs rather than
length polymorphism. With respect to minority clone
detectability, amplicon sequencing overcame this
pitfall of length polymorphism methods and also per-
formed very well in field samples.
Amplicon sequencing showed an excellent resolution
when using the novel genotyping marker cpmp
(PF3D7_0104100). The strategy applied for down-
selecting highly diverse regions in the genome suggested
cpmp as the top candidate. Cpmp is most abundantly
expressed in sporozoite stages [19], but the function of
the encoded protein is unknown. The gene is under bal-
ancing selection with a Tajima’s D of 1.16 in Guinea and
1.05 in Gambia [20]. In this study, cpmp revealed a gen-
etic diversity similar to the length polymorphic region of
the widely-used marker msp2. 45 SNPs were observed in
the 37 field samples of this study, leading to the designa-
tion of 27 haplotypes for marker cpmp. With increasing
number of field samples processed, additional rare SNPs
and even more haplotypes are likely to be found. The di-
versity of cpmp was high also in the global MalariaGEN
Table 3 Summary of genotyping results from three molecular










msp2 CE 0.948 2.19 NA 25 Reference
cpmp 0.957 2.41 45 27 0.71b (good)
csp 0.574 1.54 10c 4 0.38d (poor)
a With respect to the reference sequence of P. falciparum strain 3D7
b Cohen’s Kappa (2 raters, weights = equal): z = 6.64, p-value = 3.04e-11
c 4/10 SNPs are fixed within these 37 field samples
d Cohen’s Kappa (2 raters, weights = equal): z = 4.48, p-value = 7.61e-6
Table 4 Concordance of haplotype calls in replicates of 37 field samples
cpmp csp Passed cut-offa
Haplotype frequency within sample ≥ 1%
present in both replicates 87 57 yes
present in single replicate only 0 0 no
Haplotype frequency within sample < 1%
present in both replicates at ≥ 3 readsb 2 0 yes
present in both replicates one ≥ 3 readsb and one < 3 readsb 1c 0 yes/nod
present in single replicate at ≥ 3 readsb 17e 2 yes/nod
present in both replicates at < 3 readsb 1 0 no
present in single replicate at < 3 readsb 10 5 no
Bold rows indicate haplotypes that did pass cut-off criteria in both replicates
a Default cut-off criteria to accepted haplotype ≥3 reads and a minority clone detection limit of 1:1000
b Owing to default cut-off for haplotype call
c Second replicate had too low coverage to detect ≥3 reads
d Potential false haplotype calls as only one replicate passed cut-off criteria
e In 2 instances second replicate had too low coverage to detect minority clone
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dataset (He = 0.93); its resolution as genotyping marker
in other geographic regions remains to be shown. In
contrast, marker csp, analysed in parallel to cpmp and
also used in earlier studies, showed a limited diversity
with only 4 haplotypes detected in 37 field samples. Earl-
ier studies reported similar low diversity for csp in re-
gions of Asia Pacific [21]. Thus, csp is not suited to
serve as a single genotyping marker in PNG. However,
the global diversity of csp according to the MalariaGEN
dataset seems to be high (He = 0.86), and high diversity
has also been observed in African isolates [21].
Implementing amplicon sequencing required parallel
development of a bioinformatics pipeline. A known prob-
lem in sequence analysis is the robust detection of minor-
ity clones from a background of experimentally induced
artefacts. We addressed this problem with the design of
HaplotypR, a software package dedicated to stepwise ana-
lyse of sequence reads for samples containing multiple
clones. The HaplotypR pipeline can be divided into three
steps: In the first step, this pipeline de-multiplexes and
clusters raw sequence reads to clusters of related se-
quences, so called “representative haplotypes”. This step
employs Swarm2 software, which expands pools of ampli-
cons (identical sequence reads) by iteratively joining other
pools of amplicons that are separated by a defined number
of mismatches (e.g. one substitution, insertion or deletion)
[22, 23]. This strategy permits unbiased clustering of se-
quence reads without the need to define a list of SNPs.
This enables capturing of previously unknown SNPs with-
out any adjustments to the pipeline. In the next step Hap-
lotypR checks all representative haplotypes for presence of
PCR artefacts (indels and chimeras), and labels and cen-
sors these. In the final step HaplotypR removes back-
ground noise by applying defined cut-offs and reports a
list of final haplotypes calls.
Validation of HaplotypR was made possible by reads
from serial dilutions of P. falciparum culture strain 3D7
and from controlled mixtures of strains HB3 and 3D7.
On those control samples the impact of amplification
and sequencing errors could be assessed. An increased
frequency of sequence mismatches relative to the 3D7
reference sequence of up to 22% was observed at a few
specific genomic locations including the sequences of
amplified primers. To differentiate these sequencing
errors from true genotypes of rare minority clones,
we defined a SNP calling cut-off where a genotype
was required to be dominant (>50% of all reads) in at
least 2 samples. This cut-off is critical to distinguish
true positive genotypes that are rare in the population
from sequencing errors.
To prevent reporting of false haplotypes, HaplotypR
pipeline applies two types of cut-offs: firstly, a cut-off for
singleton exclusion, whereby a SNP or haplotype needed
to be supported by more than one sample. It is unlikely
that these cut-offs would remove true haplotypes, except
if the sample size was very small. In this case, it is rec-
ommended to amplify and sequence samples in dupli-
cate, as in this study. A true haplotype is expected to be
present in both replicates and thus will not get excluded.
Secondly, a cut-off for haplotype coverage was defined
requiring that a haplotype is supported by a user-defined
number of sequence reads. This flexible cut-off can be
selected for each marker. The coverage cut-off removes
false or weakly supported haplotypes and thus improves
specificity. On the other hand, the ability to detect mi-
nority clones (i.e. sensitivity) will be limited by a cut-off
based on coverage. Sequence reads from a minority
clone were detected in all ratios up to 1:3000 in the mix-
tures of strains HB3 and 3D7. However, due to high
background noise, false haplotypes with a frequency of
up to 0.01% were also detected, making the definition of
a cut-off to remove background noise obligatory.
Applying these default cut-offs in HaplotypR decreased
minority clone detectability from 1:3000 to 1:1000.
In an other publication a parasite density specific cut-
off was applied in addition to a default cut-off [24].
The potential of amplicon sequencing for genotyping
samples of very low parasitaemia was assessed in serial
dilutions of strain 3D7. Sequence reads were retrieved
from samples of a parasitaemia as low as 5 parasites/μl,
however coverage was below 100 reads for the lowest
level of parasitaemia. To reliably genotype samples span-
ning a wide range of parasitaemias, similar sequence
coverage (and thus unbiased normalization of input ma-
terial) for all samples is needed. The inexpensive strategy
used to adjust amplicon concentrations of individual
samples to equal levels prior to pooling for highly multi-
plexed sequencing still resulted in fluctuation in the se-
quence coverage, but a commercial DNA normalisation
kit may improve equimolar pooling of samples [25, 26].
All samples in this study were sequenced in 2 replicates.
This was done to assess the reproducibility of amplicon
sequencing method of genotyping very low abundant mi-
nority clones, and to investigate the effect of nested PCR
cycle number on artefacts. Analysing replicates of field
Table 5 Mean proportion of singleton or chimeric reads and
indels detected in both field sample replicates













csp 11.55 3.78a 0.00 11.47 4.05a 0.00
cpmp 9.76 0.073b 0.631c 9.74 0.034b 0.130c
a Marker csp: Indels Replicate 1 versus 2; Student’s t-Test: t = −1.336,
df = 71.052, p-value = 0.1858
b Marker cpmp: Indels Replicate 1 versus 2; Student’s t-Test: t = 1.3304,
df = 71.94, p-value = 0.1876
c Marker cpmp: Chimera Replicate 1 versus 2; Student’s t-Test: t = 2.3552,
df = 55.4, p-value = 0.02208
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samples revealed that haplotypes with a frequency of >1%
were consistently detected in both replicates. In contrast,
haplotypes with a frequency of <1% were frequently de-
tected only in a single replicate. If minority clones of <1%
frequency are to be reliably detected, amplifying and
sequencing two or more replicates for each sample would
be essential to call true haplotypes.
To detect minority clones with high sensitivity and
specificity, samples need to be sequenced at high cover-
age and in replicates. As sensitivity may be adjusted by
sequence coverage, choices have to be made in a trade-
off between sequencing costs and sensitivity. The spe-
cific genotyping application can guide this choice. For
example, in large scale field studies with many samples,
a high degree of multiplexing of samples at moderate se-
quence coverage may be chosen to keep sequencing cost
low. Furthermore, a less sensitive approach without per-
forming replicates may be sufficient when detection of
very rare minority clones is less of an issue. Another im-
portant application of genotyping of malaria parasites is
the example of “recrudescence typing” during in vivo
drug efficacy trials. To distinguish a new infection from
one present as a minority clone prior to drug adminis-
tration requires highest sensitivity and every clone must
be reliably detected. In such cases a sequencing ap-
proach with less multiplexing is desired to achieve high
coverage and maximal detection of minority clones.
The power of high sequencing coverage was shown for
example in a study assessing the subclonal diversity in car-
cinomas [27]. Minority variants with a frequency of 1:10′
000 were detected with a sequence depth of 100′000 reads
per sample. Our results reported from malaria field sam-
ples does not have sufficient sequence depth to achieve
such sensitivity, as median sequencing depth per sample
was 1′490 reads for cpmp and 731 reads for csp owing to
a high number of samples and of markers sequenced in
parallel. A total of 352 samples were multiplexed in a sin-
gle sequence run. Samples simultaneously processed but
not included in the present analysis served for an unre-
lated research question. According to our protocol for
PCR-based sequencing library preparation, costs per sam-
ple for Amp-Seq were twice that of msp2-CE genotyping
[5]. Thus, the approach applied by us is cost effective as it
permits parallel processing of several hundred samples, a
range typically encountered in population-wide studies.
Targeted amplicon sequencing is not only used for in-
vestigating genetic diversity of Plasmodium parasites, but
also widely applied in other fields, e.g. to study diversity of
other pathogens, diversity in eco-systems or sequence al-
teration caused by CRISPER/Cas9 [8–11, 24, 28–31]. For
pooling of multiple samples in one sequencing run, indi-
vidual samples are generally either labelled by ligating a
sequencing adapter that carries an index sequence [28] or
by amplification with the sequencing adapter carrying an
index and linker sequence [29, 30]. Data analysis follows
two main strategies to retrieve haplotypes either by clus-
tering of the full sequence read [10, 22, 24] or by SNP call-
ing and optional haplotype inference [13, 28].
Conclusions
Short amplicon sequencing has the advantage that no
multi-locus haplotype reconstruction is needed, as all
SNPs are linked by a single paired-end read. This allows
the reliable analysis of samples of very high MOI, a pre-
requisite for genotyping in areas of high malaria endem-
icity. An additional strength of this method is that
previously undescribed or newly evolving haplotypes can
be captured without any adjustment of the typing meth-
odology or the HaplotypeR pipeline. The main limiting
factor for the detection of minority clones was the se-
quence depth per sample. The sequence coverage in the
present study was in the order of 1000 reads (median
number of reads for cpmp was 1490 and for csp 731).
This permitted detection of minority clones at a fre-
quency of >0.3% of the total parasite load. To robustly
detect minority clones at 0.1% frequency, a coverage of
10′000 reads is recommended. In addition, experiments
should be performed in duplicate. The need to detect
such low-abundance clones depends on the specific re-
search question, which should guide experimental deci-
sion on number of samples and multiplexed amplicons
as well as on the desired sequence depth.
The specification of amplification and sequencing er-
rors presented here as well as the developed bioinfor-
matic tools to handle such complex analytical tasks are
relevant to all amplification-based genotyping methods
of multiple clones or quasi-species within a sample. The
newly developed pipeline can be used to analyse any
amplicon sequencing based genotyping data irrespective
of marker or organism.
Methods
Parasite genomic DNA
P. falciparum in vitro culture strains HB3 and 3D7
were mixed in 8 different proportions to generate
well defined control samples with known MOI and
well defined ratios of genomes. The ratios in these
HB3-3D7 mixtures ranged from 1:1 to 1:3′000. Five
additional control samples represented a dilution
series of strain 3D7 with parasite densities ranging
from 50′000 to 5 parasite/μl. Dilutions were prepared
in human gDNA to reconstitute the nucleic acid con-
centration of a human blood sample. Details of para-
site quantification were published previously [7].
Thirty-seven archived field samples from a cohort
study conducted in East Sepik Province, Papua New
Guinea (PNG) in 2008 were used to validate the
Lerch et al. BMC Genomics  (2017) 18:864 Page 10 of 13
performance of protocols for genotyping and data
analysis in natural P. falciparum infections [32].
Genotyping using length polymorphic marker msp2
For determination of mean MOI field samples were geno-
typed using the classical P. falciparum genotyping marker
msp2. Fluorescently labelled nested PCR products were
sized by CE on an automated sequencer and analysed using
GeneMapper software according to previously published
protocols [5]. Each DNA sample was genotyped twice in in-
dependent laboratories to assess reproducibility of clone
multiplicity (Fig. 3 and Additional file 1: Figure S9).
Amplicon deep sequencing marker selection and assay
development
3′411 genomes from 23 countries, published by the
Plasmodium falciparum Community Project
(MalariaGEN), were screened to identify highly diverse
markers for SNP-based genotyping [17]. The P. falciparum
genomes were divided in 200 bp windows and He was cal-




where n is the number of clones and pi the frequency of al-
lele i. Annotated genes (PlasmoDB v11.0) that overlapped
with windows of high heterozygosity were selected for fur-
ther evaluation. Genes belonging to gene families, such as
var, rifin, stevor and surf families, were excluded from the
list, as well as genes with high heterozygosity that is usually
caused by length polymorphism (Additional file 2).
Primers for marker cpmp were designed manually. Loca-
tion of primers was selected to flank a region of maximum
diversity (Additional file 1: Figure S1 and S2). Amplicon
sizes were limited to a maximum of 500 bp to conform to
possible read lengths of the Illumina MiSeq platform.
Quality control of primers was assessed with online tools





zer.html) [33]. Primer sequences are listed in Additional
file 1: Table S1 and He values for amplicons are shown in
Additional file 1: Figure S1 and S2.
Sequencing library preparation
The sequencing library was generated by 3 rounds of
PCR with KAPA HiFi HotStart ReadyMix PCR Kit as de-
scribed earlier [30]. A first round of 25 cycles amplified
the gene of interest. A second marker-specific nested
PCR amplified the primary product with primers that
carried a 5′ linker sequence. We compared different
cycle numbers for this second round: 25 cycles for repli-
cate 1 and 15 cycles for replicate 2. This comparison
was done to test for effects of cycle number on sequence
diversity caused by imperfect polymerase fidelity [34].
To allow pooling and later de-multiplexing of amplicons,
a third and final amplification was performed using
primers binding to the F and R Linker sequence at the
3′ end, that introduced a sample-specific molecular bar-
code sequence plus the Illumina sequence adapter at the
5′ end. The relative positions of all these elements are
depicted in the schematic in Additional file 1: Figure S4.
A detailed PCR protocol containing primer sequences,
cycle conditions und pooling steps are described in
Additional file 1.
PCR products were purified with NucleoMag beads.
The expected fragment size of the sequencing library
was confirmed by Agilent 2200 Tapestation System.
DNA concentration of the sequencing library was quan-
tified by Qubit Fluorometer (Thermo Fisher Scientific).
Sequencing was performed on an Illumina MiSeq plat-
form in paired-end mode using Illumina MiSeq reagent
kit v2 (500-cycles) together with a Enterobacteria phage
PhiX control (Illumina, PhiXControl v3).
Bioinformatic analysis pipeline “HaplotypR”
Sequence reads were mapped with bowtie2 (parameter:
end-to-end and sensitive) [35] to the phiX174 genome
(Accession: J02482.1) for assessing the quality of the se-
quencing run and calculating sequencing error per nu-
cleotide position. Reads were then de-multiplexed to
separate individual samples and different genotyping
markers (Fig. 5). Primer sequences were truncated, the
sequence was trimmed according to the quality of the
phiX control sequence reads and paired reads were
fused together.
For analysis of control samples, fused reads were mapped
to the corresponding primers and P. falciparum reference
sequences of strains 3D7 and HB3 (Accession: AL844502.2,
AL844501.2, AB121018.1, AANS01000117.1). Rates of mis-
matches to primer and reference sequences were calculated
for each individual sample at each nucleotide position. A
SNP was defined as a nucleotide position with a > 50% mis-
match rate in the sequence reads from at least two
independent samples.
For prediction of haplotypes, fused reads were clustered
individually per sample with Swarm2 software (parameters:
boundary = 3 and fastidious mode) [22, 23]. The centre of
each cluster represents the most abundant sequence of the
cluster and thus constitutes a predicted haplotype. The
cluster size represents the within-sample clone frequency
in the tested sample. Haplotypes with a cluster size of 1
were classified as singletons and considered background
noise. Haplotypes were checked for PCR artefacts such as
indels and chimeric reads. Indels are caused by polymerase
slippage which occurred primarily at stretches of homo-
polymers. Chimeric reads, caused by incomplete primer
extension and inhomologous re-annealing, were identified
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with vsearch software (parameters: uchime_denovo mode,
mindiffs = 3, minh = 0.2) [36]. To distinguish chimera hap-
lotypes resulting from PCR artefacts from true recombined
haplotypes, a population-wide approach (combining all
samples of the entire study) is implemented in Haplo-
typR. A chimera was classified as such if a haplotype
was identified as chimera by vsearch at all instances
it occurred. On the other hand, if a chimera was de-
tected in only some of the samples, it was not classi-
fied as chimera, but as a true haplotype. However, in
such instances this haplotype was always flagged and
the outcome “true chimera” or “true haplotype” was
resolved by using replicates. This approach is justified,
as it is expected that a true recombinant haplotype
would be transmitted without its parent haplotypes.
The full analysis pipeline, named HaplotypR, was im-
plemented as R package and is illustrated in Figure 5
(https://github.com/lerch-a/HaplotypR.git).
Estimated detectability of minority clones by sampling
Detectability of minority clones was estimated by
bootstrapping from the reads of the control samples
with defined HB3-3D7 strain ratios. Reads were ran-
domly sampled with replacement until the required
coverage was reached. These resampled set of reads
were processed in the same manner as the original
samples using HaplotypR. For resampling only se-
quence files from HB3-3D7 mixtures were used that
had a coverage of >3000 reads.
Additional files
Additional file 1: Supporting information. Supplementary text, figures
and tables. (DOCX 2111 kb)
Additional file 2: List of 200 bp He windows of whole P. falciparum
genome. (XLSX 96 kb)
Additional file 3: List of haplotype calls. (XLSX 67 kb)
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